Ascend Wellness Holdings (AAWH) Total Current Liabilities (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Total Current Liabilities of $88.5 million in Q1 2026, down 18.85% quarter-over-quarter from $109.0 million in Q4 2025, and down 40.2% on a YoY basis from $147.9 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Total Current Liabilities (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $88.5 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 40.2% year-over-year to $88.5 million; the TTM figure through Mar 2026 stood at $88.5 million (down 40.2% YoY), while the FY2025 annual figure was $109.0 million, down 24.58% from the prior year.
- Total Current Liabilities was $88.5 million for Q1 2026 at Ascend Wellness Holdings, down from $109.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $147.9 million in Q1 2025 to a low of $88.5 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $116.2 million across 5 years, with a median of $109.8 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities surged 55.95% in 2024, then plunged 40.2% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $110.9 million in 2022, then slipped by 16.46% to $92.7 million in 2023, then soared by 55.95% to $144.5 million in 2024, then decreased by 24.58% to $109.0 million in 2025, then decreased by 18.85% to $88.5 million in 2026.
- The last three Total Current Liabilities figures came in at $88.5 million (Q1 2026), $109.0 million (Q4 2025), and $96.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 88.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.46 Mn |
| Dec 31, 2025 | 109.01 Mn |
| Sep 30, 2025 | 96.00 Mn |
| Jun 30, 2025 | 100.79 Mn |
| Mar 31, 2025 | 147.92 Mn |
| Dec 31, 2024 | 144.54 Mn |
| Sep 30, 2024 | 145.13 Mn |
| Jun 30, 2024 | 103.06 Mn |
| Mar 31, 2024 | 103.44 Mn |
| Dec 31, 2023 | 92.69 Mn |
| Sep 30, 2023 | 129.76 Mn |
| Jun 30, 2023 | 124.65 Mn |
| Mar 31, 2023 | 109.81 Mn |
| Dec 31, 2022 | 110.95 Mn |
| Sep 30, 2022 | 137.50 Mn |
| Jun 30, 2022 | 122.04 Mn |
| Mar 31, 2022 | 109.33 Mn |
| Dec 31, 2021 | 117.40 Mn |
| Sep 30, 2021 | 104.89 Mn |
| Jun 30, 2021 | 110.22 Mn |